Amgen Enters Anti-Obesity Drug RaceWith early data and a possible advantage, Amgen enters the obesity drug race Amgen Enters Anti-Obesity Drug Race

A “14.5% total body weight loss certainly looks promising!” Katherine Saunders, an obesity specialist and founder of the obesity-focused telehealth company Intellihealth, wrote in an email.

Read more at STAT or at The Advisory Board.